子宫内放置曼月乐节育环治疗子宫腺肌症的临床观察  

Clinical observation of levonorgestrel intrauterine system in uterus treating adenomyosis

作　　者：朱少萍[1] 罗小茶[1] 黄慧文[1] 林小凤[1] 梁金兴[1] 

机构地区：[1]广东省江门市人口和计划生育服务中心计划生育科,广东江门529000

出　　处：《中国当代医药》2015年第16期96-98,共3页China Modern Medicine

摘　　要：目的：探讨子宫内放置曼月乐节育环治疗子宫腺肌症的临床效果。方法选取本院2010年2月~2014年10月收治的84例子宫腺肌症患者作为研究对象，随机分为对照组和研究组，每组42例。对照组采用药物治疗，研究组采用曼月乐节育环进行治疗，比较两组治疗前后痛经改善情况、子宫体积、血清CA125、血红蛋白及临床疗效。结果研究组的治疗总有效率为88.1%，而对照组仅为69.0%，两组差异有统计学意义（P〈0.05），且研究组的痛经症状、血清CA125改善情况优于对照组（P〈0.05）。结论曼月乐节育环置于子宫内治疗子宫腺肌症的效果确切、安全性高，具有较高的临床推广价值。Objective To investigate the clinical efficacy of levonorgestrel intrauterine system in uterus treating adeno-myosis. Methods 84 patients with adenomyosis treated in our hospital from February 2010 to October 2014 were se-lected as research objects,and they were randomly divided into control group and study group,with 42 cases in each group.control group was treated with medicine,study group was treated with levonorgestrel intrauterine system.dysmenor-rhea improvement,uterine volume,serum CA125,hemoglobin and clinical efficacy before and after treatment were com-pared between two groups. Results The total marked rate in study group was 88.1%,while in control group,it was 69.0%with statistical difference （P〈0.05）,symptoms of dysmenorrheal,decreased serum CA125 in study group was better than that in control group （P〈0.05）. Conclusion Levonorgestrel intrauterine system placed in the uterus adenomyosis treat-ment is effective and safe,which has a high clinical value.

关 键 词：曼月乐节育环 子宫腺肌症 临床疗效 

分 类 号：R711.71[医药卫生—妇产科学]